Aimax Bhd (XKLS:0041) Marketable Securities: RM0.00 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aimax Bhd Marketable Securities?

Aimax Bhd XKLS:0041 -33.33% Marketable Securities is RM0.00 Mil as of Sep. 2025. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Aimax Bhd's Marketable Securities for the quarter that ended in Sep. 2025 was RM0.00 Mil.

Aimax Bhd's annual Marketable Securities declined from Mar. 2020 (RM30.31 Mil) to Sep. 2022 (RM0.25 Mil) and declined from Sep. 2022 (RM0.25 Mil) to Sep. 2023 (RM0.21 Mil).


Aimax Bhd  (XKLS:0041) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Aimax Bhd Marketable Securities Related Terms


Aimax Bhd Marketable Securities Historical Data

* Premium members only.

The historical data trend for Aimax Bhd's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aimax Bhd Marketable Securities Chart

Aimax Bhd Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Mar19 Mar20 Sep22 Sep23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.05 30.31 0.25 0.21

Aimax Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.21 1.31 1.31 0.00

Aimax Bhd Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of RM0.00 Mil mean?
Aimax Bhd (XKLS:0041) has a Marketable Securities of RM0.00 Mil as of Sep. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aimax Bhd and its competitors.
Is Aimax Bhd's Marketable Securities too high?
Aimax Bhd's current Marketable Securities is RM0.00 Mil.
How does Aimax Bhd's Marketable Securities compare to HON and MMM?
Aimax Bhd's Marketable Securities of RM0.00 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Conglomerates company?
A good Marketable Securities depends on the Conglomerates industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Aimax Bhd and its competitors. Aimax Bhd's current Marketable Securities is RM0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Aimax Bhd (XKLS:0041) is currently considered Fairly Valued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.01 — trading right at its estimated fair value. The current Marketable Securities is RM0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Aimax Bhd (XKLS:0041), the current Marketable Securities is RM0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aimax Bhd Business Description

Address C-01-3, Block C Plaza Glomac, No 6, Jalan SS7/19, Kelana Jaya, Petaling Jaya, SGR, MYS, 47301
Aimax Bhd, formerly known as Hong Seng Consolidated Bhd, is operating as an investment holding company. The company operates in four operating segments. The healthcare segment consists of a medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods; the Financial services include Moneylending; the Gloves segment consists of Manufacturing and trading of rubber gloves; and Seafood segment which consists of Trading of Seafood products. The majority of the revenue is derived from the healthcare segment.